Lv6
2260 积分 2022-05-24 加入
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
17天前
已完结
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
21天前
已完结
Docetaxel in Second-Line Treatment of non—small-Cell Lung Cancer
28天前
已完结
Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial
1个月前
已完结
Response assessment criteria for brain metastases: proposal from the RANO group
2个月前
已完结
The KRYSTAL-1 study of adagrasib — a new trial for KRASG12C-mutated non-small-cell lung cancer
2个月前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
3个月前
已完结
Response assessment criteria for brain metastases: proposal from the RANO group
4个月前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
7个月前
已完结
皖公网安备34019202002308
